These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Long-term safety of orbital radiotherapy for Graves' ophthalmopathy. Marcocci C; Bartalena L; Rocchi R; Marinò M; Menconi F; Morabito E; Mazzi B; Mazzeo S; Sartini MS; Nardi M; Cartei F; Cionini L; Pinchera A J Clin Endocrinol Metab; 2003 Aug; 88(8):3561-6. PubMed ID: 12915636 [TBL] [Abstract][Full Text] [Related]
24. [The role of radiotherapy in Graves' ophthalmopathy]. Jaulerry C J Fr Ophtalmol; 2004 Sep; 27(7):825-7. PubMed ID: 15499286 [TBL] [Abstract][Full Text] [Related]
25. [The role of radiotherapy in endocrine orbitopathy]. Feyerabend T; Richter E; Buschmann W; Becker W; Herbolsheimer M; Pingel B Klin Monbl Augenheilkd; 1989 Jul; 195(1):1-6. PubMed ID: 2796225 [TBL] [Abstract][Full Text] [Related]
26. Assessment of a carcinogenic risk for treatment of Graves' ophthalmopathy in dependence on age and irradiation geometry. Broerse JJ; Snijders-Keilholz A; Jansen JT; Zoetelief J; Klein C; Seegenschmiedt MH Radiother Oncol; 1999 Dec; 53(3):205-8. PubMed ID: 10660199 [TBL] [Abstract][Full Text] [Related]
27. Orbital radiation for graves ophthalmopathy: a report by the American Academy of Ophthalmology. Bradley EA; Gower EW; Bradley DJ; Meyer DR; Cahill KV; Custer PL; Holck DE; Woog JJ Ophthalmology; 2008 Feb; 115(2):398-409. PubMed ID: 18082885 [TBL] [Abstract][Full Text] [Related]
28. [Effects of external orbital radiotherapy on the oculomotor muscle in Graves disease]. Maalouf T; Angioi-Duprez K; Beckendorff V; Malet T; George JL J Fr Ophtalmol; 1996; 19(12):748-54. PubMed ID: 9033899 [TBL] [Abstract][Full Text] [Related]
29. [The combined therapy of Basedow's ophthalmopathy with retrobulbar radiotherapy and i.v. immunoglobulins. The preliminary results]. Antonelli A; Saracino A; Alberti B; Melosi A; Cartei F; Lepri A; Laddaga M; Baschieri L Clin Ter; 1992 Jan; 140(1):25-31. PubMed ID: 1526094 [TBL] [Abstract][Full Text] [Related]
30. Risk of developing radiogenic cancer following photon-beam radiotherapy for Graves' orbitopathy. Mazonakis M; Tzedakis A; Lyraraki E; Damilakis J Med Phys; 2018 Oct; 45(10):4775-4782. PubMed ID: 30105825 [TBL] [Abstract][Full Text] [Related]
31. Prognostic factors in the radiotherapy of Graves' ophthalmopathy. Petersen IA; Kriss JP; McDougall IR; Donaldson SS Int J Radiat Oncol Biol Phys; 1990 Aug; 19(2):259-64. PubMed ID: 2118493 [TBL] [Abstract][Full Text] [Related]
32. Follow-up of extended pterional orbital decompression in severe Graves' ophthalmopathy. Korinth MC; Ince A; Banghard W; Gilsbach JM Acta Neurochir (Wien); 2002 Feb; 144(2):113-20; discussion 120. PubMed ID: 11862510 [TBL] [Abstract][Full Text] [Related]
38. High voltage orbital radiotherapy and surgical orbital decompression in the management of Graves' ophthalmopathy. Pigeon P; Orgiazzi J; Berthezene F; Gerard JP; Haguenauer JP; Mornex R Horm Res; 1987; 26(1-4):172-6. PubMed ID: 3110042 [TBL] [Abstract][Full Text] [Related]
39. Graves' ophthalmopathy in patients treated with radioiodine 131-I. Bałdys-Waligórska A; Gołkowski F; Kusnierz-Cabala B; Buziak-Bereza M; Hubalewska-Dydejczyk A Endokrynol Pol; 2011; 62(3):214-9. PubMed ID: 21717402 [TBL] [Abstract][Full Text] [Related]
40. The risk of radiation-induced carcinogenesis after external beam radiotherapy of Graves' orbitopathy. Akmansu M; Dirican B; Bora H; Gurel O Ophthalmic Res; 2003; 35(3):150-3. PubMed ID: 12711842 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]